Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > Clinical Development

Researchers enthusiastic over Obama’s new $215m precision medicine initiative

30-Jan-2015 - In what was largely a pep rally for science, President Obama on Friday unveiled his $215m precision medicine initiative before a crowd of industry, government and academic scientists and congressmen.

News in brief

BioClinica, Theorem join ACRO as new members

30-Jan-2015 - The Association of Clinical Research Organizations (ACRO) is bringing in BioClinica as a regular member and Theorem Clinical Research as an associate member.

Parexel sees book-to-bill bounce back as GSK strategic partnership renewal bears fruit

30-Jan-2015 - One quarter after announcing a disappointing book-to-bill ratio, CRO Parexel has now renewed its strategic partnership with GlaxoSmithKline and seen its book-to-bill ratio jump to its highest level since 2012.

Industry welcomes Energy and Commerce paper to help expedite clinical trials

28-Jan-2015 - Guidance to remove red tape in the clinical trial process has been commended by the industry body ACRO.

Strong US Dollar to hit revenues but strategic CROs may see lower costs

28-Jan-2015 - The strengthening US Dollar will reduce CRO revenues, say analysts, but firms which have global strategic deals could benefit from reduced operational costs.

update - GVK is 'respectful' of EMA recommendation and is working with customers

EMA recommends suspending drugs tested by GVK at Hyderabad site

23-Jan-2015 - The EMA has called for the suspension or withdrawal of medicines whose approval was based on testing by Indian CRO GVK Biosciences.

CRO Simbec-Orion lands Phase III lupus trial with fast-tracked compound

23-Jan-2015 - ImmuPharma and the recently formed CRO Simbec-Orion Group have entered into a collaboration to run a Phase III clinical study of the potential lupus treatment Lupuzor. Financial terms of the...

PPD adds cell-based assay services in Ireland to service EU demand

22-Jan-2015 - PPD is expanding its GMP services in Ireland to support regulatory requirements for the growing number of biopharmaceutical drugs in development.

Australian CRO expands Hong Kong operations to meet growing demand

22-Jan-2015 - Sydney-based contract research organization Novotech has expanded its Hong Kong operations with a new permanent office and prospects for four more staffers to meet the increasing demand in the research...


Consolidation among small CROs could drive up prices, says analyst

21-Jan-2015 - Competition among small CROs kept prices steady in 2014 despite higher sponsor R&D spending and greater outsourcing penetration, according to a Citi Research survey.

NIH funds more awards for infectious disease early trials

21-Jan-2015 - The US National Institutes of Health (NIH) has awarded funding to a third organisation performing early-stage clinical trials of infectious disease drugs.

Top CROs tight lipped about rumoured Pfizer deal

20-Jan-2015 - Quintiles has said Pfizer will “remain a customer” after analysts said the CRO lost out to a privately-owned contractor in the race to be the drug giant's third alliance partner.

Novartis-Qualcomm deal leads race to bring wearable tech to pharma

19-Jan-2015 - Big pharma and CROs looking to exploit wearable technology in clinical trials will need to overcome reliability and regulatory problems, says an expert.

Institute of Medicine adds voice to calls for trial transparency

16-Jan-2015 - The US Institute of Medicine has come out strongly in favour of sharing clinical trial results and says funding should be withheld from studies which do not make data public.

Clinipace closes $50m round of financing after massive growth period

16-Jan-2015 - With a three-year growth rate of 348% and the addition of over 450 jobs from 2012 to 2014, CRO Clinipace is now chasing acquisitions after closing a $50m round of...

WCCT to work with NIH institute on human flu research

16-Jan-2015 - Southern California-based CRO WCCT Global is collaborating with the National Institute of Allergy and Infectious Diseases (NIAID) on influenza research. 

US congressmen plan bill to help speed new trials, treatments to market

15-Jan-2015 - A bipartisan bill that aims to expedite the release of new treatments by modernizing clinical trials is in the works.

Quintiles looks to take advantage of Covance-LabCorp deal

15-Jan-2015 - As the second-largest central labs provider in the world, Quintiles is looking at the LabCorp acquisition of the world’s leading central labs provider Covance as a way to potentially nab...

Global spend and outsourcing trend will benefit top 5 CROs, says Icon

14-Jan-2015 - The top five CROs will increase their market share as pharma continues to up both R&D spending and outsourcing, according to Icon.

AMRI looks to replace Allegra royalty revenue with contract revenue

14-Jan-2015 - 2015 is the year that AMRI loses its royalties for discovering the API of Allegra and the company is now looking to its string of recent acquisitions and new contract...

Novella partners with research foundation to collaborate on cardiovascular trials

14-Jan-2015 - Quintiles subsidiary Novella Clinical and the academic research arm of the Cardiovascular Research Foundation (CRF) are collaborating to offer pre-clinical to post-market trial services to developers of cardiovascular drugs and devices. ...

Parexel strong book-to-bill 'reassuring' for CRO demand, says analyst

13-Jan-2015 - Parexel’s improved book-to-bill ratio is a reassuring sign for the company and the CRO industry as a whole, according to a William Blair analyst.

PPD’s X-Chem signs multi-target collaboration with Janssen

12-Jan-2015 - PPD’s recently acquired biotech company X-Chem is launching a multi-target collaboration with Janssen Biotech. Financial terms of the deal were not disclosed.  

Tufts: Outsourcing to increase as sponsors re-think R&D strategies in 2015

09-Jan-2015 - CROs are due to see an increasing workload in 2015, though the way they conduct trials with partners may continue to shift, according to the Tufts Center for the Study...

Japan to be hot destination for trials in 2015 say experts, despite drop in MRCTs last year

09-Jan-2015 - Japan was involved in fewer drug industry-sponsored multi-regional clinical trials (MRCT) in 2014 than any year since 2008 according to the Pharmaceuticals and Medical Devices Agency (PDMA).

Key Industry Events


Access all events listing

Our events, Shows & Conferences...